| SCHRODER ISF EMERGING MARKETS MULTI-ASSET A MDIS AUD (HEDGED) | MIXTO FLEXIBLE | 52,12% | 52,25% | 4,15% | 3,35% |
| FIDELITY FUNDS-ASIA EQUITY ESG Y-ACC-EUR (HEDGED) | RVI ASIA EX-JAPÓN | 52,10% | 68,69% | 32,91% | · |
| DWS INVEST GOLD AND PRECIOUS METALS EQUITIES LD | RVI MATERIAS PRIMAS | 52,09% | 158,49% | 124,45% | 164,83% |
| JPM THEMATICS-GENETIC THERAPIES A (DIST) USD | RVI BIOTECNOLOGÍA | 52,09% | 22,99% | -21,66% | · |
| POLAR CAPITAL HEALTHCARE DISCOVERY I USD CAP | RVI SALUD | 52,09% | 30,00% | 14,07% | · |
| UBS (LUX) EQUITY SICAV - GLOBAL EMERGING MARKETS OPPORTUNITY (USD) Q-ACC | RVI EMERGENTES CRECIMIENTO | 52,09% | 80,92% | 36,74% | · |
| JPM THEMATICS-GENETIC THERAPIES C (DIST) USD | RVI BIOTECNOLOGÍA | 52,08% | 23,65% | -20,54% | · |
| VONTOBEL FUND-MTX EMERGING MARKETS LEADERS NG USD CAP | RVI EMERGENTES | 52,08% | 81,73% | · | · |
| PRIVILEDGE - AMERICAN CENTURY EMERGING MARKETS EQUITY (USD) M DIS | RVI EMERGENTES | 52,07% | 83,68% | 31,99% | · |
| PICTET - ASIAN EQUITIES EX JAPAN I EUR | RVI ASIA EX-JAPÓN | 52,04% | 74,96% | 31,61% | 167,52% |
